.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

QuintilesIMS
Deloitte
Cantor Fitzgerald
AstraZeneca
Chinese Patent Office
Mallinckrodt
Accenture
McKinsey
Cipla
Merck

Generated: February 25, 2018

DrugPatentWatch Database Preview

Suppliers and packages for generic ingredient: tolazamide

« Back to Dashboard

Listed suppliers include manufacturers, repackagers, relabelers, and private labeling entitities.

Applicant Tradename Generic Name Dosage NDA NDA/ANDA Supplier Package Code Package
Mylan Pharms IncTOLAZAMIDEtolazamideTABLET;ORAL070259ANDAMylan Pharmaceuticals Inc.N0378-0217-01
Mylan Pharms IncTOLAZAMIDEtolazamideTABLET;ORAL070259ANDAMylan Pharmaceuticals Inc.N0378-0551-01
Mylan Pharms IncTOLAZAMIDEtolazamideTABLET;ORAL070259ANDAPD-Rx Pharmaceuticals, Inc.N55289-265-90
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

McKinsey
Chinese Patent Office
McKesson
Moodys
US Army
AstraZeneca
Accenture
Harvard Business School
Healthtrust
Cipla

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot